Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5155)
Hims & Hers Health, Inc. (HIMS)
Chi Michael — Chief Operating Officer
Shares
14,027
Price
$31.50
Total Value
$441.85K
Shares Held After
432,124
% of Holdings
3.1%
Hims & Hers Health, Inc. (HIMS)
Becklund Irene — PAO
Shares
4,490
Price
$31.50
Total Value
$141.44K
Shares Held After
6,790
% of Holdings
39.8%
Hims & Hers Health, Inc. (HIMS)
Elshenawy Mohamed — CTO
Shares
30,040
Price
$31.50
Total Value
$946.26K
Shares Held After
101,023
% of Holdings
22.9%
Acumen Pharmaceuticals, Inc. (ABOS)
Porter Derrell — Director
Shares
13,040
Price
$2.33
Total Value
$30.32K
Shares Held After
35,500
% of Holdings
26.9%
Eton Pharmaceuticals, Inc. (ETON)
Adams Jennifer McKie — Director
Shares
50,000
Price
$32.48
Total Value
$1.62M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
5,195
Price
$70.36
Total Value
$365.52K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
26,856
Price
$70.36
Total Value
$1.89M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
779
Price
$70.36
Total Value
$54.81K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
32,751
Price
$70.36
Total Value
$2.30M
Shares Held After
0
% of Holdings
100.0%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
4,697
Price
$60.71
Total Value
$285.15K
Shares Held After
65,045
% of Holdings
6.7%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
5,303
Price
$59.97
Total Value
$318.02K
Shares Held After
69,742
% of Holdings
7.1%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
1,537
Price
$130.68
Total Value
$200.86K
Shares Held After
88,833
% of Holdings
1.7%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,613
Price
$3.18
Total Value
$11.49K
Shares Held After
129,102
% of Holdings
2.7%
Warby Parker Inc. (WRBY)
Briggs Teresa — Director
Shares
1,908
Price
$26.79
Total Value
$51.12K
Shares Held After
48,883
% of Holdings
3.8%
Warby Parker Inc. (WRBY)
Briggs Teresa — Director
Shares
3,092
Price
$25.41
Total Value
$78.57K
Shares Held After
50,791
% of Holdings
5.7%
RadNet, Inc. (RDNT)
Wesdorp Cornelis — Pres & CEO, Digital Health
Shares
4,750
Price
$58.11
Total Value
$276.02K
Shares Held After
69,075
% of Holdings
6.4%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — President, Research and Development
Shares
4,175
Price
$156.12
Total Value
$651.80K
Shares Held After
291,876
% of Holdings
1.4%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
2,157
Price
$156.12
Total Value
$336.75K
Shares Held After
56,521
% of Holdings
3.7%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
2,722
Price
$156.12
Total Value
$424.96K
Shares Held After
123,269
% of Holdings
2.2%
Ridgetech Inc. (RDGT)
HRT FINANCIAL LP — 10% Owner
Shares
57,998
Price
$1.60
Total Value
$92.85K
Shares Held After
61,753
% of Holdings
48.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
10,020
Price
$156.12
Total Value
$1.56M
Shares Held After
267,330
% of Holdings
3.6%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
4,615
Price
$156.12
Total Value
$720.49K
Shares Held After
49,975
% of Holdings
8.5%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
3,132,480
Price
$0.01
Total Value
$40.72K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
333
Price
$266.69
Total Value
$88.81K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,710
Price
$265.99
Total Value
$454.84K
Shares Held After
333
% of Holdings
83.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,650
Price
$264.87
Total Value
$437.04K
Shares Held After
2,043
% of Holdings
44.7%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
590
Price
$265.98
Total Value
$156.93K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
1,169
Price
$265.39
Total Value
$310.24K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
1,357
Price
$266.76
Total Value
$362.00K
Shares Held After
0
% of Holdings
100.0%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
22,139
Price
$3.31
Total Value
$73.19K
Shares Held After
81,353
% of Holdings
21.4%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
6,961
Price
$69.92
Total Value
$486.70K
Shares Held After
54,324
% of Holdings
11.4%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
11,651
Price
$68.76
Total Value
$801.10K
Shares Held After
61,285
% of Holdings
16.0%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
1,457
Price
$29.95
Total Value
$43.64K
Shares Held After
18,086
% of Holdings
7.5%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
14,960
Price
$17.36
Total Value
$259.71K
Shares Held After
411,861
% of Holdings
3.5%
CASTLE BIOSCIENCES INC (CSTL)
Oelschlager Kristen M — Chief Operating Officer
Shares
8,587
Price
$20.71
Total Value
$177.84K
Shares Held After
30,460
% of Holdings
22.0%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
5,823
Price
$83.57
Total Value
$486.63K
Shares Held After
1,094,543
% of Holdings
0.5%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
4,177
Price
$82.69
Total Value
$345.42K
Shares Held After
1,100,366
% of Holdings
0.4%
NATIONAL HEALTHCARE CORP (NHC)
HASSAN EMIL E — Director
Shares
1,563
Price
$199.97
Total Value
$312.56K
Shares Held After
71,532
% of Holdings
2.1%
10x Genomics, Inc. (TXG)
SULIMAN SHEHNAAZ — Director
Shares
364
Price
$33.27
Total Value
$12.11K
Shares Held After
31,722
% of Holdings
1.1%
10x Genomics, Inc. (TXG)
SULIMAN SHEHNAAZ — Director
Shares
5,359
Price
$32.59
Total Value
$174.64K
Shares Held After
32,086
% of Holdings
14.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
20,000
Price
$7.90
Total Value
$157.99K
Shares Held After
756,000
% of Holdings
2.6%
LIGAND PHARMACEUTICALS INC (LGND)
Sabba Stephen L — Director
Shares
2,145
Price
$254.00
Total Value
$544.83K
Shares Held After
33,629
% of Holdings
6.0%
Natera, Inc. (NTRA)
Chapman Rowan E — Director
Shares
2,964
Price
$216.78
Total Value
$642.54K
Shares Held After
3,124
% of Holdings
48.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
6,160
Price
$18.01
Total Value
$110.94K
Shares Held After
1,405,898
% of Holdings
0.4%
Hims & Hers Health, Inc. (HIMS)
Becklund Irene — PAO
Shares
7,573
Price
$30.25
Total Value
$229.08K
Shares Held After
11,280
% of Holdings
40.2%
DAVITA INC. (DVA)
Rodriguez Javier — Director
Shares
39,407
Price
$209.28
Total Value
$8.25M
Shares Held After
840,408
% of Holdings
4.5%
Acumen Pharmaceuticals, Inc. (ABOS)
Porter Derrell — Director
Shares
12,800
Price
$2.33
Total Value
$29.77K
Shares Held After
35,500
% of Holdings
26.5%
Korro Bio, Inc. (KRRO)
Vincent Loic A — Chief Scientific Officer
Shares
3,418
Price
$10.83
Total Value
$37.02K
Shares Held After
18,297
% of Holdings
15.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
210
Price
$554.63
Total Value
$116.47K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
386
Price
$553.10
Total Value
$213.50K
Shares Held After
40,723
% of Holdings
0.9%
Showing 51–100 of 5155 transactions (page 2 of 104)